Xenova Group PLC
19 March 2001
Not for release, publication or distribution in or into the United States,
Canada, Australia or Japan
Xenova Group plc ('Xenova')
Recommended Merger Offer for Cantab Pharmaceuticals plc ('Cantab')
Result of Extraordinary General Meeting
Xenova announces that, at an Extraordinary General Meeting held earlier today,
the resolution relating to the recommended merger offer by Nomura
International plc ('Nomura') on behalf of Xenova for Cantab (the 'Merger
Offer') was duly passed.
The first closing date of the Merger Offer is Thursday, 22nd March 2001.
Cantab shareholders are reminded that acceptances of the Merger Offer should
be returned as soon as possible and in any event so as to be received by no
later than 3.00 p.m. on that day.
David Oxlade, Xenova 01753 706600
David Porter, Nomura 020 7521 2000
David Yates, Financial Dynamics 020 7831 3113
Nomura, which is regulated in the United Kingdom by The Securities and Futures
Authority Limited, is acting for Xenova and no one else in connection with the
Merger Offer and will not be responsible to anyone other than Xenova for
providing the protections afforded to customers of Nomura or for providing
advice in relation to the Merger Offer.
This announcement has been approved by Nomura for the purposes of Section 57
of the Financial Services Act 1986.